Baylor College of Medicine, Houston
Paper discusses biomarkers in inflammatory process leading to atherothrombosis
Published in Cardiovascular Business Week, June 28th, 2005
"Inflammation plays an important role in the initiation and progression of atherosclerosis and the development of atherosclerotic events. Understanding the molecular basis of inflammation has led to the identification of markers that may also serve as new targets of therapy in the management of atherothrombotic disease," researchers in the United States report.
C. Ballantyne and colleagues of the Baylor College of Medicine continued, "Inflammatory markers, Such as C-reactive protein (CRP), have been shown to predict future cardiovascular events in individuals with and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- MacroPore Biosurgery, Inc.
Regenerative medicine company receives $11 million from equity placement - SIH Telemedicine
Israel-based telemedicine systems developer reports Q1 2005 results, contracts - Sophion Bioscience A/S
Danish producer of patch clamping devices reports on sales, marketing, growth - Sorin Group
Developer of technologies or cardiac surgery reports on stockholders meeting - The LEO Pharma Research Foundation
Malignant ascites researcher receives grant - Abaxis, Inc.
Company releases Lipid Panel Plus - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
